PrIME Biologics is a Singapore company developing biological products for health and wellness through proprietary technology.
Founded in 2010 in Singapore, PrIME Biologics develops biological products for health applications, including regenerative medicine and therapeutics, for healthcare providers, research institutions and consumers in North America, Europe and Asia. The company is at the Series A stage. It raised SGD 16 mn in Series A funding in May 2014 from investors including Xeraya Capital and JP Asia Capital. In 2016 it reported revenue of SGD 246,404.30.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in